Press release
October 29, 2026
Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial
Kymera Therapeutics, Inc. (KYMR)
We couldn't retrieve the full text for this release. Read it on the company's site.